{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,28]],"date-time":"2026-10-28T07:42:25Z","timestamp":1793173345879,"version":"4.5.0"},"reference-count":47,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2018,12,1]],"date-time":"2018-12-01T00:00:00Z","timestamp":1543622400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,12,1]],"date-time":"2018-12-01T00:00:00Z","timestamp":1543622400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100015758","name":"Novo Nordisk Pharma","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100015758","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004948","name":"Astellas Pharma","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004948","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100015990","name":"Sanofi K.K.","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100015990","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100012351","name":"Mitsubishi Tanabe Pharma Corporation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100012351","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100016288","name":"Kissei","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100016288","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100013170","name":"Ono Pharmaceutical","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100013170","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100017346","name":"Boehringer Ingelheim Japan","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100017346","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100014422","name":"Eli Lilly Japan","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100014422","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004095","name":"Kyowa Hakko Kirin","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004095","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100005570","name":"Takeda Pharmaceuticals North America","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100005570","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100012781","name":"MSD K.K.","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100012781","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004325","name":"AstraZeneca","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004325","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002336","name":"Daiichi Sankyo Company","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100002336","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","em-consulte.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinics and Research in Hepatology and Gastroenterology"],"published-print":{"date-parts":[[2018,12]]},"DOI":"10.1016\/j.clinre.2018.06.005","type":"journal-article","created":{"date-parts":[[2018,7,23]],"date-time":"2018-07-23T19:52:51Z","timestamp":1532375571000},"page":"570-576","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":15,"title":["Low urine pH is a risk for non-alcoholic fatty liver disease: A population-based longitudinal study"],"prefix":"10.1016","volume":"42","author":[{"given":"Takuro","family":"Okamura","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8794-0550","authenticated-orcid":false,"given":"Yoshitaka","family":"Hashimoto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8651-4445","authenticated-orcid":false,"given":"Masahide","family":"Hamaguchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Akihiro","family":"Obora","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takao","family":"Kojima","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michiaki","family":"Fukui","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.clinre.2018.06.005_bib0240","doi-asserted-by":"crossref","first-page":"1508","DOI":"10.3748\/wjg.v18.i13.1508","article-title":"Identification of individuals with non-alcoholic fatty liver disease by the diagnostic criteria for the metabolic syndrome","volume":"18","author":"Hamaguchi","year":"2012","journal-title":"World J Gastroenterol"},{"key":"10.1016\/j.clinre.2018.06.005_bib0245","doi-asserted-by":"crossref","first-page":"997","DOI":"10.1016\/j.dld.2015.08.004","article-title":"Epidemiological modifiers of non-alcoholic fatty liver disease: focus on high-risk groups","volume":"47","author":"Lonardo","year":"2015","journal-title":"Dig Liver Dis"},{"key":"10.1016\/j.clinre.2018.06.005_bib0250","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1007\/s12020-017-1313-6","article-title":"Fatty liver as a risk factor for progression from metabolically healthy to metabolically abnormal in non-overweight individuals","volume":"57","author":"Hashimoto","year":"2017","journal-title":"Endocrine"},{"key":"10.1016\/j.clinre.2018.06.005_bib0255","doi-asserted-by":"crossref","first-page":"1141","DOI":"10.1111\/j.1464-5491.2005.01582.x","article-title":"Prevalence of non-alcoholic fatty liver disease and its association with impaired glucose metabolism in Japanese adults","volume":"22","author":"Jimba","year":"2005","journal-title":"Diabet Med"},{"key":"10.1016\/j.clinre.2018.06.005_bib0260","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1111\/liv.12912","article-title":"The impact of non-alcoholic fatty liver disease on incident type 2 diabetes mellitus in non-overweight individuals","volume":"36","author":"Fukuda","year":"2016","journal-title":"Liver Int"},{"key":"10.1016\/j.clinre.2018.06.005_bib0265","doi-asserted-by":"crossref","first-page":"e1001680","DOI":"10.1371\/journal.pmed.1001680","volume":"11","author":"Musso","year":"2014","journal-title":"PLoS Med"},{"key":"10.1016\/j.clinre.2018.06.005_bib0270","doi-asserted-by":"crossref","first-page":"e6712","DOI":"10.1097\/MD.0000000000006712","article-title":"Non-overweight non-alcoholic fatty liver disease and incident cardiovascular disease: a post-hoc analysis of a cohort study","volume":"96","author":"Yoshitaka","year":"2017","journal-title":"Medicine (Baltimore)"},{"key":"10.1016\/j.clinre.2018.06.005_bib0275","doi-asserted-by":"crossref","first-page":"1341","DOI":"10.1056\/NEJMra0912063","article-title":"Risk of cardiovascular disease in patients with non-alcoholic fatty liver disease","volume":"363","author":"Targher","year":"2010","journal-title":"N Engl J Med"},{"key":"10.1016\/j.clinre.2018.06.005_bib0280","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1016\/j.clnu.2015.03.008","article-title":"High dietary acid load is associated with insulin resistance: the Furukawa nutrition and health study","volume":"35","author":"Akter","year":"2016","journal-title":"Clin Nutr"},{"key":"10.1016\/j.clinre.2018.06.005_bib0285","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1016\/j.biochi.2015.09.012","article-title":"The role of dietary acid load and mild metabolic acidosis in insulin resistance in humans","volume":"124","author":"Williams","year":"2016","journal-title":"Biochimie"},{"key":"10.1016\/j.clinre.2018.06.005_bib0290","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1507\/endocrj.K10E-319","article-title":"Association of urine acidification with visceral obesity and the metabolic syndrome","volume":"58","author":"Otsuki","year":"2011","journal-title":"Endocr J"},{"key":"10.1016\/j.clinre.2018.06.005_bib0295","doi-asserted-by":"crossref","first-page":"1438","DOI":"10.3945\/ajcn.111.022343","article-title":"Dietary acid load and risk of hypertension: the Rotterdam Study","volume":"95","author":"Engberink","year":"2012","journal-title":"Am J Clin Nutr"},{"key":"10.1016\/j.clinre.2018.06.005_bib0300","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1111\/jdi.12326","article-title":"Lower vegetable protein intake and higher dietary acid load associated with lower carbohydrate intake are risk factors for metabolic syndrome in patients with type\u00a02 diabetes: post-hoc analysis of a cross-sectional study","volume":"6","author":"Iwase","year":"2015","journal-title":"J Diabetes Investig"},{"key":"10.1016\/j.clinre.2018.06.005_bib0305","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1159\/000443746","article-title":"Dietary acid load and incident chronic kidney disease: results from the ARIC study","volume":"42","author":"Rebholz","year":"2015","journal-title":"Am J Nephrol"},{"key":"10.1016\/j.clinre.2018.06.005_bib0310","doi-asserted-by":"crossref","first-page":"846","DOI":"10.1002\/hep.21496","article-title":"The NAFLD fibrosis score: a non-invasive system that identifies liver fibrosis in patients with NAFLD","volume":"45","author":"Angulo","year":"2007","journal-title":"Hepatology"},{"key":"10.1016\/j.clinre.2018.06.005_bib0315","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1053\/jhep.2002.30692","article-title":"NASH and insulin resistance: insulin hypersecretion and specific association with the insulin resistance syndrome","volume":"35","author":"Chitturi","year":"2002","journal-title":"Hepatology"},{"key":"10.1016\/j.clinre.2018.06.005_bib0320","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1038\/nature13478","article-title":"The role of hepatic lipids in hepatic insulin resistance and type 2 diabetes","volume":"510","author":"Perry","year":"2014","journal-title":"Nature"},{"key":"10.1016\/j.clinre.2018.06.005_bib0325","doi-asserted-by":"crossref","first-page":"74","DOI":"10.3164\/jcbn.16-118","article-title":"Urinary pH reflects dietary acid load in patients with type 2 diabetes","volume":"61","author":"Miki","year":"2017","journal-title":"J Clin Biochem Nutr"},{"key":"10.1016\/j.clinre.2018.06.005_bib0330","doi-asserted-by":"crossref","first-page":"1335","DOI":"10.1017\/S0007114507862350","article-title":"Urine pH is an indicator of dietary acid\u2013base load, fruit and vegetables and meat intakes: results from the European Prospective Investigation into Cancer and Nutrition (EPIC)-Norfolk population study","volume":"99","author":"Welch","year":"2008","journal-title":"Br J Nutr"},{"key":"10.1016\/j.clinre.2018.06.005_bib0335","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.diabres.2017.04.023","article-title":"Urinary pH is a predictor of diabetes in men; a population based large scale cohort study","volume":"130","author":"Hashimoto","year":"2017","journal-title":"Diabetes Res Clin Pract"},{"key":"10.1016\/j.clinre.2018.06.005_bib0340","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1159\/000330487","article-title":"Low urine pH is a predictor of chronic kidney disease","volume":"35","author":"Nakanishi","year":"2012","journal-title":"Kidney Blood Press Res"},{"key":"10.1016\/j.clinre.2018.06.005_bib0345","doi-asserted-by":"crossref","DOI":"10.2169\/internalmedicine.0167-17","article-title":"Low urine pH is associated with non-alcoholic fatty liver disease: a community-based cross-sectional study","author":"Miyake","year":"2018","journal-title":"Intern Med"},{"key":"10.1016\/j.clinre.2018.06.005_bib0350","doi-asserted-by":"crossref","first-page":"722","DOI":"10.7326\/0003-4819-143-10-200511150-00009","article-title":"The metabolic syndrome as a predictor of non-alcoholic fatty liver disease","volume":"143","author":"Hamaguchi","year":"2005","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.clinre.2018.06.005_bib0355","doi-asserted-by":"crossref","first-page":"546","DOI":"10.1111\/jgh.12786","article-title":"The modest alcohol consumption reduces the incidence of fatty liver in men: a population-based large-scale cohort study","volume":"30","author":"Hashimoto","year":"2015","journal-title":"J Gastroenterol Hepatol"},{"key":"10.1016\/j.clinre.2018.06.005_bib0360","doi-asserted-by":"crossref","first-page":"2232","DOI":"10.2215\/CJN.07400715","article-title":"Acid-base homeostasis","volume":"10","author":"Hamm","year":"2015","journal-title":"Clin J Am Soc Nephrol"},{"key":"10.1016\/j.clinre.2018.06.005_bib0365","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1373\/clinchem.2006.078980","article-title":"Gamma-glutamyltransferase as a predictor of chronic kidney disease in nonhypertensive and nondiabetic Korean men","volume":"53","author":"Ryu","year":"2007","journal-title":"Clin Chem"},{"key":"10.1016\/j.clinre.2018.06.005_bib0370","doi-asserted-by":"crossref","first-page":"982","DOI":"10.1053\/j.ajkd.2008.12.034","article-title":"Revised equations for estimated GFR from serum creatinine in Japan","volume":"53","author":"Matsuo","year":"2009","journal-title":"Am J Kidney Dis"},{"key":"10.1016\/j.clinre.2018.06.005_bib0375","doi-asserted-by":"crossref","first-page":"578","DOI":"10.2215\/CJN.08980914","article-title":"Metabolically healthy obesity and risk of incident CKD","volume":"10","author":"Hashimoto","year":"2015","journal-title":"Clin J Am Soc Nephrol"},{"key":"10.1016\/j.clinre.2018.06.005_bib0380","doi-asserted-by":"crossref","first-page":"1422","DOI":"10.1111\/j.1523-1755.2004.00522.x","article-title":"Association of urinary pH with body weight in nephrolithiasis","volume":"65","author":"Maalouf","year":"2004","journal-title":"Kidney Int"},{"key":"10.1016\/j.clinre.2018.06.005_bib0385","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1016\/j.metabol.2011.06.026","article-title":"High serum uric acid level and low urine pH as predictors of metabolic syndrome: a retrospective cohort study in a Japanese urban population","volume":"61","author":"Hara","year":"2012","journal-title":"Metabolism"},{"key":"10.1016\/j.clinre.2018.06.005_bib0390","article-title":"Relationship between urine pH and abnormal glucose tolerance in a community-based study","author":"Yoshida","year":"2017","journal-title":"J Diabetes Investig"},{"key":"10.1016\/j.clinre.2018.06.005_bib0395","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1111\/j.1523-1755.2004.00386.x","article-title":"The metabolic syndrome and uric acid nephrolithiasis: Novel features of renal manifestation of insulin resistance","volume":"65","author":"Abate","year":"2004","journal-title":"Kidney Int"},{"key":"10.1016\/j.clinre.2018.06.005_bib0400","doi-asserted-by":"crossref","first-page":"883","DOI":"10.2215\/CJN.00670207","article-title":"Low urine pH: a novel feature of the metabolic syndrome","volume":"2","author":"Maalouf","year":"2007","journal-title":"Clin J Am Soc Nephrol"},{"key":"10.1016\/j.clinre.2018.06.005_bib0405","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1055\/s-2007-982517","article-title":"Relationship between insulin resistance and low urinary pH in patients with gout, and effects of PPAR \u03b1 agonists on urine pH","volume":"39","author":"Takahashi","year":"2007","journal-title":"Horm Metab Res"},{"key":"10.1016\/j.clinre.2018.06.005_bib0410","doi-asserted-by":"crossref","first-page":"F1171","DOI":"10.1152\/ajprenal.1987.253.6.F1171","article-title":"Insulin stimulates ammoniagenesis in canine renal proximal tubular segments","volume":"253","author":"Chobanian","year":"1987","journal-title":"Am J Physiol Physiol"},{"key":"10.1016\/j.clinre.2018.06.005_bib0415","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1152\/ajprenal.1991.260.5.F695","article-title":"Insulin increases Na(+)-H+ exchange activity in proximal tubules from normotensive and hypertensive rats","volume":"260","author":"Gesek","year":"1991","journal-title":"Am J Physiol Physiol"},{"key":"10.1016\/j.clinre.2018.06.005_bib0420","doi-asserted-by":"crossref","first-page":"532","DOI":"10.1152\/ajprenal.00365.2001","article-title":"Insulin activates Na(+)\/H(+) exchanger 3: biphasic response and glucocorticoid dependence","volume":"283","author":"Klisic","year":"2002","journal-title":"Am J Physiol Renal Physiol"},{"key":"10.1016\/j.clinre.2018.06.005_bib0425","doi-asserted-by":"crossref","first-page":"1315","DOI":"10.1152\/ajprenal.00550.2007","article-title":"Effect of renal lipid accumulation on proximal tubule Na+\/H+ exchange and ammonium secretion","volume":"294","author":"Bobulescu","year":"2008","journal-title":"Am J Physiol Renal Physiol"},{"key":"10.1016\/j.clinre.2018.06.005_bib0430","doi-asserted-by":"crossref","first-page":"550","DOI":"10.2215\/CJN.04071206","article-title":"Obesity and obesity-initiated metabolic syndrome: mechanistic links to chronic kidney disease","volume":"2","author":"Wahba","year":"2007","journal-title":"Clin J Am Soc Nephrol"},{"key":"10.1016\/j.clinre.2018.06.005_bib0435","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1089\/met.2010.0108","article-title":"Metabolic acidosis-induced insulin resistance and cardiovascular risk","volume":"9","author":"Souto","year":"2011","journal-title":"Metab Syndr Relat Disord"},{"key":"10.1016\/j.clinre.2018.06.005_bib0440","doi-asserted-by":"crossref","first-page":"125","DOI":"10.4239\/wjd.v6.i1.125","article-title":"Roles of interstitial fluid pH in diabetes mellitus: glycolysis and mitochondrial function","volume":"6","author":"Marunaka","year":"2015","journal-title":"World J Diabetes"},{"key":"10.1016\/j.clinre.2018.06.005_bib0445","doi-asserted-by":"crossref","first-page":"e0154345","DOI":"10.1371\/journal.pone.0154345","article-title":"Association between triglyceride to HDL-C Ratio (TG\/HDL-C) and insulin resistance in Chinese patients with newly diagnosed type 2 diabetes mellitus","volume":"11","author":"Ren","year":"2016","journal-title":"PLoS One"},{"key":"10.1016\/j.clinre.2018.06.005_bib0450","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1111\/liv.12977","article-title":"Triglycerides to high-density lipoprotein cholesterol ratio is an independent predictor of incident fatty liver: a population-based cohort study","volume":"36","author":"Fukuda","year":"2016","journal-title":"Liver Int"},{"key":"10.1016\/j.clinre.2018.06.005_bib0455","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1007\/s00240-011-0365-y","article-title":"Fasting versus 24-h urine pH in the evaluation of nephrolithiasis","volume":"39","author":"Capolongo","year":"2011","journal-title":"Urol Res"},{"key":"10.1016\/j.clinre.2018.06.005_bib0460","doi-asserted-by":"crossref","first-page":"1211","DOI":"10.2215\/CJN.03230312","article-title":"Does the exposure of urine samples to air affect diagnostic tests for urine acidification?","volume":"7","author":"Yi","year":"2012","journal-title":"Clin J Am Soc Nephrol"},{"key":"10.1016\/j.clinre.2018.06.005_bib0465","doi-asserted-by":"crossref","first-page":"778","DOI":"10.1111\/j.1440-1746.2007.05001.x","article-title":"Non-alcoholic fatty liver disease in the Asia? Pacific region: definitions and overview of proposed guidelines","volume":"22","author":"Chitturi","year":"2007","journal-title":"J Gastroenterol Hepatol"},{"key":"10.1016\/j.clinre.2018.06.005_bib0470","article-title":"Ectopic fat obesity presents the greatest risk for incident type 2 diabetes: a population-based longitudinal study","author":"Okamura","year":"2018","journal-title":"Int J Obes (Lond)"}],"container-title":["Clinics and Research in Hepatology and Gastroenterology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2210740118301177?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2210740118301177?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,31]],"date-time":"2025-10-31T07:27:54Z","timestamp":1761895674000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2210740118301177"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,12]]},"references-count":47,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2018,12]]}},"alternative-id":["S2210740118301177"],"URL":"https:\/\/doi.org\/10.1016\/j.clinre.2018.06.005","relation":{},"ISSN":["2210-7401"],"issn-type":[{"value":"2210-7401","type":"print"}],"subject":[],"published":{"date-parts":[[2018,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Low urine pH is a risk for non-alcoholic fatty liver disease: A population-based longitudinal study","name":"articletitle","label":"Article Title"},{"value":"Clinics and Research in Hepatology and Gastroenterology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.clinre.2018.06.005","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Published by Elsevier Masson SAS.","name":"copyright","label":"Copyright"}]}}